Risk of nondherence to diabetes medications among medicare advantage enrollees: Development of a validated risk prediction tool

Medicine & Life Sciences

• Medicare Part C 97%
• Hypoglycemic Agents 58%
• Managed Care Programs 42%
• Centers for Medicare and Medicaid Services (U.S.) 31%
• Prescriptions 31%
• Organizations 30%
• Medicare 25%
• meglitinide 21%
• Statistics 19%
• Biguanides 17%
• Dipeptidyl-Peptidase IV Inhibitors 16%
• Thiazolidinediones 16%
• Prescription Drugs 14%
• Medication Adherence 13%
• Pharmacists 12%
• Risk Assessment 10%
• Area Under Curve 10%
• Observational Studies 9%
• Sensitivity and Specificity 9%
• Insulin 8%
• Aptitude 8%
• Retrospective Studies 8%
• Health Care Outcome Assessment 8%
• Population 4%

Social Sciences

• chronic illness 61%
• medication 52%
• drug 41%
• managed care 34%
• statistics 15%
• rating 15%
• pharmacist 11%
• risk assessment 9%
• event 5%

Chemical Compounds

• Oral Antidiabetic Agent 100%
• Prescription Drug 20%
• Biguanides 20%
• Dipeptidyl Peptidase IV Inhibitor 19%
• Area Under the Curve 17%
• Risk Assessment 14%
• Insulin Derivative 12%